GlassScriptPhysician profile
Howard B Weiss
NPI 1508952045
$647.32
in general payments reported to CMS, 2019-2025
8 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
See the full distribution for Sports Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.87 · 2020: $14.85 · 2022: $38.74 · 2023: $127 · 2024: $335 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $310.79 | 2022-2025 | Botox |
| Merz Pharmaceuticals, LLC | $123.03 | 2024 | Xeomin |
| Amneal Pharmaceuticals LLC | $68.64 | 2023-2024 | Lyvispah, Lioresal (Baclofen) |
| Team 1, LLC | $63.09 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $24.87 | 2019 | |
| Nevro Corp. | $22.91 | 2024 | Senza |
| Coloplast Corp | $19.14 | 2025 | |
| Allergan, INC. | $14.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.